Under the deal, Medtronic will provide telehealth devices for LHC’s existing care transitions programme, Transitions, Training and Triage (T3), which is a disease management approach that was clinically proven to reduce emergency room visits and prevent avoidable readmissions.

Specifiaclly, LHC will use Commander Flex remote patient monitoring devices, which will offer home telehealth management and education for patients with complex conditions such as heart failure, hypertension, COPD, and diabetes.

The Commander Flex system will allow LHC to carry out the daily monitoring of symptoms and vital signs to predict events, assess risk and communicate with patients before an acute event such as hospitalisation.

Medtronic senior vice-president and Americas region president Mike Genau said: "Medtronic recognizes that in order to better address the changing needs and challenges of healthcare systems, we need to provide new solutions to help our customers maximize value and improve care."

"We’re excited to be leveraging our expertise in therapy innovation and the capabilities of Cardiocom, our Patient Monitoring Services business, to create new value-based healthcare solutions."

LHC Group offers home health, hospice and comprehensive post-acute healthcare services in the US.

Image: Medtronic operational headquarters, Minneapolis. Photo: courtesy of Medtronic, Inc.